Related Experiment Video
Updated: Jan 27, 2026

Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis
Fenfang Zou1, Jianpeng Zhang1, Guoan Xiang1
1Department of Respiratory, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Abstract:
Published data on the association between MMP-9 polymorphisms (-1562 C > T, rs3918242; Gln279Arg, rs17576 Arg668Gln, rs17577) and asthma susceptibility are inconclusive. To derive a more precise estimation of this association, a meta-analysis was performed. A literature search was conducted in PubMed, Web of Science, EMBASE, Wanfang, and China National Knowledge Infrastructure (CNKI) databases to identify eligible studies. The pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to calculate the strength of association. Sensitivity analysis was performed to evaluate the influence of individual studies on the overall effect estimates, and funnel plots and Egger's test were inspected for indication of publication bias. Seven studies with 1592 asthma patients and 1987 controls were finally identified. Overall, we found no significant association between -1562 C > T, rs3918242 polymorphism, and asthma susceptibility in any of the genetic model comparisons. After categorizing studies into different subgroups on the basis of ethnicity and age, there is still no significant association. For the Gln279Arg, rs17576 polymorphism, there seems to be a significant association in the allelic genetic model in regard to the P value (OR = 1.11, 95% CI = 1.00-1.22, I 2 = 0%, P (Z)=0.044); however, the value of lower 95% CI is 1.0. For the Arg668Gln, rs17577 polymorphism, a high significant association was observed in the dominant model comparison (OR = 1.65, 95% CI = 1.28-2.11, I 2 = 22.50%, P (Z)=0), recessive model comparison (OR = 2.40, 95% CI = 1.23-4.72, I 2 = 0%, P (Z)=0.011), homozygote genotype comparison (OR = 2.69, 95% CI = 1.36-5.33, I 2 = 0%, P (Z)=0.004), and allelic genetic model (OR = 1.59, 95% CI = 1.29-1.97, I 2 = 36.9%, P (Z)=0). Sensitivity analysis demonstrated the stability of our results, and publication bias was not evident. The present meta-analysis suggests that MMP-9 Arg668Gln, rs17577 polymorphism may be the risk factor for asthma susceptibility.
Insights
This meta-analysis found no significant link between MMP-9 -1562 C>T polymorphism and asthma. However, the MMP-9 Arg668Gln, rs17577 polymorphism may be a risk factor for asthma susceptibility.
Area of Science:
- Genetics
- Immunology
- Respiratory Medicine
Background:
- Matrix metalloproteinase-9 (MMP-9) plays a role in inflammatory processes.
- Published data on MMP-9 polymorphisms and asthma susceptibility are inconclusive.
- A comprehensive meta-analysis is needed for a precise estimation of the association.
Purpose of the Study:
- To investigate the association between MMP-9 polymorphisms (-1562 C>T, rs3918242; Gln279Arg, rs17576; Arg668Gln, rs17577) and asthma susceptibility.
- To provide a more precise estimation of these associations through meta-analysis.
Main Methods:
- A systematic literature search was conducted in multiple databases (PubMed, Web of Science, EMBASE, Wanfang, CNKI).
- Eligible studies involving asthma patients and controls were identified.
- Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, and sensitivity analyses and publication bias tests were performed.
Main Results:
- No significant association was found between the MMP-9 -1562 C>T (rs3918242) polymorphism and asthma susceptibility across all genetic models and subgroups.
- A potential borderline significant association was observed for the Gln279Arg (rs17576) polymorphism in the allelic model (OR=1.11, 95% CI=1.00-1.22).
- A highly significant association was observed for the Arg668Gln (rs17577) polymorphism in dominant, recessive, homozygote genotype, and allelic models, suggesting it as a risk factor.
Conclusions:
- The MMP-9 -1562 C>T (rs3918242) polymorphism is not associated with asthma susceptibility.
- The MMP-9 Arg668Gln (rs17577) polymorphism may represent a risk factor for asthma susceptibility.
- Further research may be warranted to elucidate the role of specific MMP-9 polymorphisms in asthma pathogenesis.
Related Concept Videos
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Directing Effect of Substituents: meta-Directing Groups

